Clinical Trials
3 trialsNCT04953871 2021-07-08
Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Phase 4 Completed
NCT01548768 2020-11-27
RHYTHM
Columbia University
Phase 4 Completed
NCT02862574 2018-06-27
Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis
Gilead Sciences
Phase 2 Terminated